Search Results

Pharm Country

Soterix Medical Launches MxN-GO EEG System for Wire-free HD-tES and EEG

Soterix Medical Inc., the global leader in non-invasive brain stimulation and synergistic monitoring technologies, announced the launch of MxN-GO EEG, a combined High Definition transcranial Electrical Stimulation and EEG system with a unique untethered design.

April 30, 2024

·

2 min read

Press Releases

Soterix Medical Announces FDA 510(k) Clearance of MEGA-IOM Intraoperative Neuromonitoring System

July 25, 2024

·

2 min read

Drug Development

Soterix Medical announces Phase-2 trial to test at-home tDCS paired with cognitive training as a therapeutic option for long COVID

Soterix Medical Inc. announces the launch of a Phase-2 clinical trial that will evaluate the combination of REMOTE-tDCS and a brain training program for the treatment of long COVID.

August 28, 2023

·

2 min read

Pharm Country

Soterix Medical Announces Patient Recruitment for Parcel-Guided rTMS Depression Trial

Soterix Medical Inc. (SMI), a global leader in non-invasive stimulation and synergistic brain monitoring technologies, announced today that patient recruitment for its treatment resistant depression trial funded by National Institute of Health has begun in New York City.

May 8, 2023

·

2 min read

Pharm Country

Soterix Medical Announces award of Fast Track NIH grant to develop a Parcel-Guided software to improve efficacy of rTMS treatment for Depression

Soterix Medical Inc. (SMI), a global leader in non-invasive neuromodulation and synergistic brain monitoring technologies, announced today that it has been awarded a Fast Track grant from the National Institute of Mental Health (NIMH).

October 13, 2022

·

2 min read

Business

Wise Therapeutics and Soterix Medical Jointly Announce Positive Results of Study Combining Gamified Digital Therapeutics with Neurostimulation Device

Wise Therapeutics (Wise), a developer of game-based digital therapeutics including Personal Zen , and Soterix Medical jointly announced the results of their collaborative study, published in Frontiers in Neuroergonomics.

June 30, 2021

·

2 min read

Press Releases

Tenon Medical(R) to Host Meetings During the 2025 J.P. Morgan Healthcare Conference in San Francisco

January 9, 2025

·

2 min read

Pharm Country

Soterix Medical Announces Expanded Clinical Trials for Alzheimer’s disease and Mild Cognitive Impairment

Soterix Medical Inc. , the global leader in non-invasive stimulation and synergistic brain imaging technologies, is pleased to report expanded clinical trials of its proprietary neuromodulation technologies for Alzheimer’s disease and Mild Cognitive Impairment. Adults over age 65 represent the fastest growing population in the US. Dec

December 24, 2020

·

3 min read

Pharm Country

Soterix Medical study to address post-COVID neurological and psychiatric symptoms using at-home neuromodulation and monitoring

Soterix Medical Inc. (SMI), the global leader in non-invasive stimulation and synergistic brain imaging technologies, announces a new clinical trial of home-based auricular Vagus Nerve Stimulation (taVNS) for individuals who experience post-COVID neuropsychiatric symptoms, like fatigue, headache, or anxiety

January 26, 2021

·

2 min read

Pharm Country

FDA Grants Soterix Medical IDE Approval for Home-based tDCS-LTE Trial for Depression

Soterix Medical Inc. announces it has received FDA Investigational Device Exception (IDE) to launch a trial of transcranial Direct Current Stimulation-Limited Total Energy (tDCS-LTE) neuromodulation at-home for patients with Major Depressive Disorder (MDD)

July 7, 2020

·

2 min read